Accustem Sciences Inc. engaged Mercurius & Associates LLP as its auditor.
“une 17, 2024, Mercurius & Associates LLP PCAOB no. 3223 (“Mercurius”) was appointed as Accustem Sciences, Inc.’s”
Source-grounded facts extracted from Accustem Sciences Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Accustem Sciences Inc. engaged Mercurius & Associates LLP as its auditor.
“une 17, 2024, Mercurius & Associates LLP PCAOB no. 3223 (“Mercurius”) was appointed as Accustem Sciences, Inc.’s”
Accustem Sciences Inc. engaged Mercurius LLP as its auditor.
“On June 17, 2024, Mercurius LLP ("Mercurius") was appointed as Accustem Sciences, Inc.’s (the "Company") independent registered public accounting firm.”
Jeff Fensterer resigned as Chief Operating Officer at Accustem Sciences Inc..
“On June 5, 2023, Jeff Fensterer, the Chief Operating Officer of AccuStem Sciences Inc. (the “Company”) resigned his position with the Company for personal reasons, effective as of June 16, 2023.”
Sean McDonald was elected as independent director at Accustem Sciences Inc..
“On November 14, 2022, the Board of Directors (the “Board”) of AccuStem Sciences, Inc. (the “Company”) increased the size of the Board to five members and elected Sean McDonald as an independent director, for a term continuing to the Company’s next annual meeting of shareholders, when all directors will be subject to election by shareholders.”
Kunwar Shalubhai resigned as member of the Board at Accustem Sciences Inc..
“On June 20, 2022, Dr. Kunwar Shalubhai notified AccuStem Sciences Inc. (the “Company”) of his decision to resign as a member of the Board, effective immediately.”
Wendy Blosser was appointed as director at Accustem Sciences Inc..
“On March 30, 2022, the Board of Directors of the Company appointed Wendy Blosser, the Company’s Chief Executive Officer as a director to serve on the Board and to hold office until the next annual meeting of stockholders and until her successor is duly elected and qualified”
Wendy Blosser was appointed as Chief Executive Officer at Accustem Sciences Inc..
“Pursuant to an agreement dated February 18, 2022 (the “Offer Letter”), Wendy Blosser was appointed Chief Executive Officer of AccuStem Sciences, Inc. effective March 4, 2022 (the “Effective Date”).”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.